vgenomics.in
Business Services · India · 51-200 Employees
View Company Info for Free
Overview
Headquarters
156 C Pocket 12 Jasola, New Delhi, Nct, ...Website
www.vgenomics.inRevenue
<$5 MillionIndustry
ZI Rank: 1
About vgenomics.in
vgenomics.in Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is vgenomics.in your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if vgenomics.in has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when vgenomics.in launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
vgenomics.in, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if vgenomics.in had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at vgenomics.in
Earning: See what the market has to say on vgenomics.in recently announced quarterly report
Funding: Get notified immidiatlly once vgenomics.in has new funding data
Check out if vgenomics.in is spiking on competitors!
Recommended Actions
Find VP level buyers at vgenomics.in
Find 3 more new buyers
Company Profile Activity
Activity Insights
vgenomics.in is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
vgenomics.in is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about vgenomics.in.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding vgenomics.in
Vgenomics specializes in diagnosing rare diseases, particularly in newborns, leveraging whole genome and exome research to enhance patient outcomes. The company is developing comprehensive blood tests capable of diagnosing over 100 rare diseases and aims to expedite therapeutic solutions from 10-15 years to 3-5 years. Their primary clients include... Read More
